Mahoney Stephen F. bought VRDN
March 3, 2026 · Form 4 insider transaction
Mahoney Stephen F. bought 18,357 shares of Viridian Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
18,357
Price
N/A
Total value
N/A
InsiderMahoney Stephen F.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 3, 2026
Filing dateMarch 4, 2026
Shares owned after40,757
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.; Includes 1,000 shares acquired under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan (the "ESPP") on March 17, 2025 in transactions that were exempt under Rule 16b-3(c).